Mandatory Notification (MN) of Mesotheliomas

Size: px
Start display at page:

Download "Mandatory Notification (MN) of Mesotheliomas"

Transcription

1 Maladies chroniques et traumatismes September 2014 Occupational health Mandatory Notification (MN) of Mesotheliomas 2012, First Year of the Program s Nationwide Operation Laurence Chérié-Challine, Nathalie Bonnet, Ellen Imbernon, with the participation of Céline Gallot Department of Occupational Health (DST), French Institute for Public Health Surveillance (InVS), Saint-Maurice, France. Mandatory Notification (MN) of Mesotheliomas 2012, First Year of the Program's Nationwide Operation After Laurence a pilot Mandatory phase Chérié-Challine, in 2011 Notification in 6 volunteer Nathalie (MN) Bonnet, regions, of Mesotheliomas mesothelioma Ellen Imbernon Department to implement of Occupational the Meso-MN Health, surveys French to improve Institute knowledge for Public became Health 2012, the Surveillance 31st First mandatory Year of the notification Program's disease Nationwide in France, Operation about occupational and environmental exposure in 3 by decree (n , January 16, 2012). This mandatory populations that experts know too little about: individuals notification with the Laurence requirement participation Chérié-Challine, applies of Céline to Nathalie all Gallot, doctors Bonnet, Department (pathologists Ellen Imbernon of Occupational and Department with Health, non-pleural of Occupational French mesothelioma, Institute Health, for French Public men Institute Health younger for Surveillance than Public 50, and clinicians) After Health a practicing pilot Surveillance phase in in metropolitan 2011 in 6 volunteer or overseas regions, France mesothelioma who women became with the pleural 31 st mandatory mesothelioma. notification disease in France, diagnose by decree a case (n , of mesothelioma, January 16, regardless 2012). This of its mandatory anatomic notification requirement applies to all doctors (pathologists and with the participation of Céline Gallot, Department of Occupational Health, French Institute for Public Health Surveillance site. clinicians) It is part of practicing the second in national metropolitan Cancer or Plan overseas and contributes France who diagnose This knowledge a case should of mesothelioma, help us to guide regardless community of its prevention anatomic After a pilot phase in 2011 in 6 volunteer regions, mesothelioma became the 31 st mandatory notification disease in France, more site. widely It by is decree part to measures of (n , the second against January national asbestos-related 16, 2012). Cancer This Plan cancers, mandatory and contributes an notification activities more requirement and widely increase to applies important medical to all steps doctors and social against (pathologists recognition asbestos-related and for the important cancers, clinicians) public an important health practicing problem. public in metropolitan health problem. or overseas France who diagnose benefit a of case individual of mesothelioma, patients. regardless The PNSM, of its in operation anatomic since site. It is part of the second national Cancer Plan and contributes 1998, more is widely the reference to important system steps for against monitoring asbestos-related and knowledge Established Established cancers, by the by an French the important French Institute public Institute for health Public for problem. Health Public Surveillance Health Surveillance of pleural (InVS) mesothelioma; at Ministry nonetheless of Health s it request cannot and describe applying the (InVS) recommendations the Ministry of of the Health s High Council request of and Public applying Health (HCSP), pleural mesothelioma mandatory notification situation of in mesothelioma districts it does has two not recommendations objectives Established intended of by the the to High further French Council Institute epidemiological of Public for Public Health knowledge: Health (HCSP), Surveillance cover. (InVS) Mandatory at the Ministry notification of Health s completes request and the applying PNSM for the recommendations of High Council of Public Health (HCSP), mandatory notification of mesothelioma has two mandatory - To use notifications of from mesothelioma doctors to strengthen has two objectives the monitoring other of all mesotheliomas, sites, to especially complete peritoneum. national program It is not of objectives intended to further epidemiological knowledge: intended mesothelioma to further surveillance epidemiological (PNSM), knowledge: which covers only cases of an pleural expert-based mesothelioma system and and only cannot in 21 districts. replace the system for - To use notifications from doctors to strengthen the monitoring of all mesotheliomas, to complete the national program of - To implement the Meso-MN surveys to improve knowledge mesothelioma surveillance (PNSM), which covers only cases of pleural reporting about mesothelioma occupational and only diseases. and environmental exposure in 3 in 21 districts. to populations use notifications - To implement that from experts the doctors Meso-MN know to strengthen too surveys little about: the to monitoring improve individuals knowledge with about non-pleural occupational mesothelioma, and environmental men younger exposure than in 3 50, and of women all mesotheliomas, populations with pleural that mesothelioma. to experts complete know the too national little about: program individuals of with non-pleural mesothelioma, men younger than 50, and mesothelioma women with surveillance pleural mesothelioma. (PNSM), which covers only cases of This pleural knowledge mesothelioma should and help only us to in 21 guide districts. community prevention activities, and increase medical and social recognition for the benefit This knowledge of individual should help patients. us to guide The PNSM, community in operation prevention activities, since 1998, and increase is the reference medical and system social recognition for monitoring for and knowledge the benefit of pleural of individual mesothelioma; patients. nonetheless The PNSM, in it operation cannot describe since 1998, the pleural is the reference mesothelioma system situation for monitoring in the and districts it does knowledge not cover. of Mandatory pleural mesothelioma; notification nonetheless completes the it cannot PNSM describe for the other pleural mesothelioma sites, situation especially in the the districts peritoneum. It does not cover. Mandatory notification completes the PNSM for the other mesothelioma sites, especially the peritoneum. It I is Figure not an is not 1 expert-based I system and cannot replace the system for reporting occupational diseases. an expert-based system and cannot replace the system for reporting occupational diseases. The The two two The components two components components of the of of the national the national national mesothelioma mesothelioma mesothelioma MN system MN MN system system The first component: national epidemiological surveillance (notification) The first component: national epidemiological surveillance (notification) French Institute for Public Health Surveillance / p. 1 1

2 The first component: national epidemiological surveillance (notification) Strong involvement of all MN participants The project is coordinated by the InVS and was developed with support from the relevant institutions (Directorate-General of Health DGS, Directorate-General of Labor DGT, and National Cancer Institute INCa). Representatives of these institutions and of various organizations and professional groups (French Society of Pathology (SFP), French-language Society of Pulmonary Medicine (SPLF), National Council of Oncology (CNC), and the National Network for rare peritoneal tumors (RENAPE), the National Reference Centre for pleural mesothelioma (Mesoclin), and Expert Pathologists Network for Mesothelioma (Mesopath)) sit on the project steering committee (COPIL). Their participation enables the communication, cooperation, and guidance necessary for the development and effective operation of the program. The MN system is organized on a regional basis, with the interregional epidemiology groups (Cellules interrégionales d épidémiologie) (CIRE-InVS), the regional health agencies (Agences régionale de santé) (ARS), regional oncology networks (RRC), and in association with the PNSM team in the regions concerned. The InVS, with its national and regional partners, is conducting numerous communication activities aimed at increasing awareness and ination among all doctors who may potentially see cases that must be notified. The regional oncology network plays an essential role in local communication, through its regional networks of potential notifiers, and seeks the active participation of all doctors who diagnose mesothelioma. Awareness among gastroenterologists is also facilitated by the national network of rare peritoneal tumors (RENAPE). Satisfactory results for 2012, the first year of notification The early results concern 618 new cases of mesothelioma diagnosed histologically in 2012 and reported through the MN program from January 2012 (when it began) to April 30, The end date is consistent with the mean notification delay of 4 months, observed during the first 6 months of notification in We note that the data presented probably do not reflect the real situation, especially in view of the non-exhaustive participation of all doctors who might diagnose mesothelioma and the permanent and developing nature of the MN system. Thus, between May 2013 and February 15, 2014, the InVS received 41 new reports of mesothelioma cases diagnosed in 2012, for a total of 659 incident cases that year, still below the number expected. I Table 1 I Summary of the characteristics of the cases diagnosed in 2012 and notified between January 2012 and April 30, 2013 Characteristics of notifications Number of cases of mesothelioma: 618 (615 in metropolitan France, 3 in Reunion, 0 in Martinique- Guadeloupe-Guyane) Notifying physicians 781 notification s, transmitted by: - pathologists: 74% - clinicians: 52% Cases notified by a pathologist and a clinician (=notification rule): 22% Mean time until transmission by metropolitan region From date of diagnosis to reception by InVS All notifications: 94 days Notifications from January to June 2012: 124 days (range: 41 to 226 days) Notifications from July to December: 63 days (13 to 116 days) Anatomic site Characteristics of mesothelioma Pleura: 89% (Men: 92% - Women: 83%) Peritoneum: 9% (Men: 7% - Women: 14%) Tunica vaginalis (testes): 2 cases Sex All sites: Men: 73% - Women: 27% Pleura: Men: 75% - Women: 25% Peritoneum: Men 58% - Women: 42% Mean age All sites: Men: 72.6 years - Women: 71.0 years Pleura: 73.4 years - Women: 72.8 years Peritoneum: Men 67.9 years - Women: 64.2 years Younger than 50 years All sites: 2.6% (Men: 1.3% - Women: 6.1%) Pleura: 1.3% (Men: 0.5% - Women: 3.8%) Peritoneum: 16.6% (Men 12.9% - Women 21.7%) p. 2 / French Institute for Public Health Surveillance Mandatory Notification (MN) of Mesotheliomas. 2012, First Year of the Program s Nationwide Operation

3 The ination about known occupational contact with asbestos was reported often When clinicians report the diagnosis directly to the regional health agency, their opinion about occupational contact with asbestos is stated directly on the ; when a pathologist notifies a case, the regional health agency contacts the clinician by telephone to obtain this ination. This variable was reported in 78% of cases. Certain or possible contact is specified in 47%, and absence of known contact in 19%. In 12% of the cases, the clinician could not answer. The level of coverage nationwide on April 30, 2013, ranges from 51% to 77% If we base our assessment on the order of magnitude of the annual number of expected cases of mesothelioma (all sites), from 800 to 1200 (source: INCa), we can consider that nationally, on April 30, 2013, the MN system had recorded 51% to 77% of the cases diagnosed in On February 15, 2014, given the 41 new cases from 2012 notified late, the level of national exhaustiveness had improved by 5%, that is, to 56% to 82%. Substantial differences in the exhaustiveness between regions There were substantial differences in the level of completeness between regions. On April 30, 2013, one third of the regions had come close to complete reporting, with the number of cases from MN of the same order of magnitude as those estimated by the PNSM and mortality similar to that reported by the PMSI and/or Cépi-Dc-INSERM. These regions include Aquitaine, Bourgogne, Limousin, the Midi-Pyrénées, the Nord- Pas-de-Calais, Picardie, and Poitou-Charentes. Inversely, the completeness of reporting remains low in some regions. We note nonetheless that the situation has since changed as a function of the notifications received for each region. The 2012 data from both the PMSI and the causes of death were not available at the time this document was written, so that comparisons were possible only for earlier years (2011 for PMSI and 2010 for mortality). I Table 2 I Comparison between regions for incident cases reported by MN and other surveillance systems DO Incident cases 2012 Range of expected number of incident cases (1) PMSI Cases 2011 (linked since 2004) Mortality Death 2010 Lower-upper range Pathologist national reference center (2) Cases assessed 2012 Alsace Aquitaine Auvergne Basse-Normandie Bourgogne Bretagne Centre Champagne-Ardenne Corse Franche-Comté Haute-Normandie Ile-de-France Languedoc-Roussillon Limousin Lorraine Midi-Pyrénées Nord-Pas-de-Calais Paca Pays de la Loire Picardie Poitou-Charentes Rhône-Alpes Total metropolitan France ,200 1, , (1) National numbers (source INCa), regional order of magnitude based on size of the regional population, without taking the differences in exposure by region into account, although they can be substantial. (2) Regional distribution of cases analyzed by experts, according to the location of the diagnosing pathologist s practice (and not the patient s home), for both primary cancers and recurrences (source Mesopath). French Institute for Public Health Surveillance / p. 3

4 Exhaustiveness must improve further to allow epidemiological surveillance These early results show that the quality of the mesothelioma MN system varies according to region. They should help to guide actions to increase the participation of both pathologists and clinicians. The modalities of its implementation must be debated within COPIL especially for national activities but also for adaptation to the situation in each region, to be discussed with each of the regional project teams. The second component, for knowledge of the exposure factors (Meso-MN surveys) In accordance with the opinion of the High Council of Public Health (HCSP) dated October 21, 2010, the InVS is setting up exposure surveys to strengthen our knowledge of the occupational and environmental factors (asbestos and other fibers) in 3 populations insufficiently known (30% of all mesotheliomas): people with non-pleural mesothelioma; women with pleural mesothelioma; men younger than 50 years with pleural mesothelioma. These Meso-MN surveys are conducted by the Department of Occupational Health (DST-InVS) with the Department of Environmental Health (DSE-InVS), the regional and alert coordination department (DCar-InVS), and the PNSM experts. They are intended to complete the exposure surveys conducted as part of PNSM. Pilot phase conducted in 2014 in 9 regions The Meso-MN surveys are being tested in 2014, for a one-year period, in 8 volunteer regions in metropolitan France (Aquitaine, Alsace, Basse-Normandie, Bretagne, Franche-Comté, Limousin, Picardie, and Poitou-Charentes) and in one overseas region (Reunion). The CNIL approved the study on May 8, 2013 (decision DR ). The patients to be surveyed are identified from the MN s received by the participating regional health agencies. Patients eligible for both the PNSM and Meso-MN surveys (men < 50 years or woman with pleural mesothelioma and living in a PNSM district) are surveyed according to the PNSM procedure. Two regional models are being tested: surveys conducted by the InVS interregional epidemiology teams (CIRE in Bretagne, Limousin, Picardie, Poitou- Charentes, and Reunion); surveys conducted by the local PNSM team, as part of an extension of the PNSM, applying the Meso-MN survey procedure (Alsace, Aquitaine, Basse-Normandie and Franche- Comté). The InVS is collaborating with the occupational health team (ESSAT) of the environmental and occupational health laboratory (Laboratoire-Santé-Travail-Environnement (LSTE)) at the University of Bordeaux: they provide an expert assessment of the exposure of case patients, based on their analysis of the survey answers. A progressive national rollout of these surveys should begin in 2015, depending on the results of the pilot phase The pilot phase will allow us to test all phases of the Meso- MN survey and to assess the time and staff necessary for the perance of each stage. It will allow us to analyze the participation rate in these surveys and the quality of questionnaire completion. It will also allow us to assess the feasibility of these surveys and their relevance for meeting our objective to strengthen knowledge of exposure to asbestos and other fibers. If the outcome is positive, recommendations will be produced for the rollout of these surveys in the other regions, both metropolitan and overseas; it will take place progressively, starting in 2015 in accordance with the local situation in each region and the budget available. In conclusion Through the support of the professional groups and societies and institutions, especially members of the COPIL, and in association with its regional partners, the InVS has been able to establish an effective national surveillance system for mesothelioma, based on a MN system. This system can and must be improved further. It is also essential to continue all together its development. Support for the national epidemiological surveillance program for mesothelioma and the development of exposure surveys are among the points included in action 12-4 ("support epidemiological surveillance and research to improve knowledge of occupational cancers") of the Cancer Plan for , launched by the president of the republic on February 4, This national program includes MN of mesothelioma and the PNSM, two linked systems complementary in terms of their objectives. InVS continues to produce regular reports updating the current epidemiological situation of mesotheliomas in France. The next MN report will cover in particular the consolidated incidence data for 2012 and the incidence data for French Institute for Public Health Surveillance / p. 4

5 Review of the notification procedure for a new case of mesothelioma Definition of a case to be notified The following cases must be notified: all new cases of mesothelioma of the pleura, the peritoneum, the pericardium, the testes vaginalis, or of any other or unspecified site, diagnosed from a pathology examination or a clinical expert assessment in the absence of a histologic examination or confirmation, based on clinical, radiologic, and ultrasound findings. Two notification s: pathologists and clinicians Can be downloaded from the InVS website (http://www. invs.sante.fr). The notifying physician must use the appropriate to his or her specialty (pathologist or clinician) and region of practice (access by pulldown menu - upper right line). Notification procedure The diagnosis is reported after it has been histologically confirmed. It comprises two stages: 1) completion of the (pathologist or clinician ) for the doctor s region of practice; 2) rapid transmission, even if incomplete, dated and signed, by fax to the doctor responsible for mandatory notifications of mesothelioma at the regional health agency of the region of practice (fax number in the regional pulldown menu). The cases to be surveyed All people with non-pleural mesothelioma. Women with pleural mesothelioma. Men younger than 50 years with pleural mesothelioma. I Figure 2 I Notification circuit of a new case of mesothelioma Notifying physicians Notifying pathologists - complete the pathologists with the ination they have available Notifying clinicians - complete the clinicians - in the patient about mandatory notification Pathologists Clinicians Physicians, Regional Health Agency (ARS) - validate the s - contact notifying physician, if necessary - establish anonymous code - send the completed and anonymized - store the identity-code data for 12 months Pathologists anonymized Clinicians anonymized Epidémiologists/InVS - validate the s - match the clinicians and pathologists s - eliminate duplicates - data entry into the national database: quality control national analyses feedback to regions French Institute for Public Health Surveillance / p. 5

6 To learn more 1. L. Chérié-Challine, N. Bonnet, E. Imbernon. Déclaration obligatoire des mésothéliomes : 2012, première année de fonctionnement du dispositif national, rapport InVS Bulletin de rétro-ination n 1 du réseau DO mésothéliomes. 3. Dossier DO sur le site de l InVS : 4. Des indicateurs en santé travail Risques professionnels dus à l amiante. Saint Maurice : Institut de veille sanitaire ; p. Available from the URL: Acknowledgments We thank : - the notifying physicians; - the regional partners (ARS-CVAGS, Cire, RRC, local PNSM team); - the professional societies (SFP, FFP, SPLF, CNC, CPHG, Renape, CNPath, Mesoclin, Mesopath); - the members of the Project steering committee (PJ. Bousquet, A. Buémi, L. Chérié-Challine, F. Capron, PL. Druais, M. Fontaine, F. Galateau-Sallé, A. Gallay, S. Gilardin, A. Gilg Soit Ilg, FN. Gilly, JP. Grignet, E. Imbernon, J. Le Moal, P. Lonchambon, F. Martin, F. May-Levin, C. Merle, T. Molina, JC. Pairon, JC. Sabourin, A. Scherpereel, A. Thuret, V. Trillet-Lenoir, S. Urban, L. Villeneuve). Key words: Mandatory notification, mesotheliomas, epidemiological surveillance, exposure surveys, France Suggested citation: Chérié-Challine L, Bonnet N, Imbernon E. Mandatory Notification (MN) of Mesotheliomas. 2012, First Year of the Program s Nationwide Operation. Saint-Maurice (Fra): French Institute for Public Health Surveillance (Institut de veille sanitaire); p. Available from the URL: French Institute for Public Health Surveillance (Institut de veille sanitaire), 12 rue du Val d Osne Saint-Maurice Cedex France Tel.: 33 (0) Fax: 33 (0) ISSN: ISBN-NET: Design/Production: Communication department InVS Legal deposit: september 2014

Main results and prospects

Main results and prospects Occupational health Maladies chroniques et traumatismes Development of national surveillance indicators for work-related traffic accidents Exploratory study from data recorded by social insurance workers

More information

Post-retirement medical surveillance of retired self-employed craftspeople exposed to asbestos (ESPrI)

Post-retirement medical surveillance of retired self-employed craftspeople exposed to asbestos (ESPrI) 100 C /45J Santé travail Maladies chroniques et traumatismes Post-retirement medical surveillance of retired self-employed craftspeople exposed to asbestos (ESPrI) Craftsmen and craftswomen from the self-employed

More information

Startups or Takeovers: Individual and regional determinants of differentiated entrepreneurial logics?

Startups or Takeovers: Individual and regional determinants of differentiated entrepreneurial logics? 4th ECFED International Workshop Klagenfurt, Austria, July 3-4, 2014. Startups or Takeovers: Individual and regional determinants of differentiated entrepreneurial logics? Rafik Abdesselam*, Jean Bonnet**,

More information

Mobile Indicator Monitor

Mobile Indicator Monitor Publication : 3rd November 28 Mobile Indicator Monitor Data at: 3th september 28 Mobile Indicator monitor at 3th September 28 Contents : National - Page 1 : Numbers and multimedia Metropolitan France -

More information

Asbestos Fibres in Indoor and Outdoor Air AND The Epidemiology of Asbestos-related Diseases in Quebec *

Asbestos Fibres in Indoor and Outdoor Air AND The Epidemiology of Asbestos-related Diseases in Quebec * Asbestos Fibres in Indoor and Outdoor Air AND The Epidemiology of Asbestos-related Diseases in Quebec * SUMMARY AND RECOMMENDATIONS OF THE REPORTS ABSTRACT In 1997, in light of international developments

More information

Indicators in Occupational Health

Indicators in Occupational Health Indicators in Health Indicators in Occupational Health Occupational risks due to asbestos Sommaire Abreviations 2 Presentation 3 1. Introduction: Asbestos, exposure, health effects 4 1.1 Asbestos: nature

More information

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology

MesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image

More information

1. 2. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS

1. 2. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS SERVIR L AVENIR * 1. 2. 3. 4. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS OUR NETWORK AT THE HEART

More information

Health effects of occupational exposure to asbestos dust

Health effects of occupational exposure to asbestos dust Health effects of occupational exposure to asbestos dust Authors: N.Szeszenia-Dąbrowska, U.Wilczyńska The major health effects of workers' exposure to asbestos dust include asbestosis, lung cancer and

More information

1. 2. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS

1. 2. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS 1. 2. 3. 4. OUR MISSION SERVIR L AVENIR * OUR EXPERTISE ACCOMPANYING ENTREPRENEURS OUR STRATEGY BRINGING TOGETHER THE BEST OF THE PUBLIC AND PRIVATE SECTORS OUR NETWORK AT THE HEART OF THE REGIONS 3-5

More information

Annual Report 2011. Organisation for the Register of Insurance Intermediaries

Annual Report 2011. Organisation for the Register of Insurance Intermediaries Organisation for the Register of Insurance Intermediaries Annual Report 2011 A r t i c l e R. 5 1 2-5 V I I I o f t h e F r e n c h I n s u r a n c e C o d e 1, r u e J u l e s L e f e b v r e 7 5 3 1

More information

Summary of treatment benefits

Summary of treatment benefits Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell

More information

Surveillance of carbon monoxide (CO) poisoning

Surveillance of carbon monoxide (CO) poisoning Surveillance of carbon monoxide (CO) poisoning Carbon monoxide is the most common cause of severe acute poisoning in France where it causes several thousand acute poisonings and several hundred deaths

More information

Workers' Compensation in Japan

Workers' Compensation in Japan Table of Contents PL-5-02 Sugio Furuya Workers' Compensation in Japan Sugio Furuya Secretary General Japan Occupational Safety and Health Resource Center (JOSHRC) Abstract Each country has its own compensation

More information

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Survey of Mesothelioma Associated with Asbestos Exposure in Japan The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics

More information

Electronic medical records

Electronic medical records Electronic medical records Country: France Partner Institute: Institut de Recherche et Documentation en Economie de la Santé (IRDES), Paris Survey no: (8)2006 Author(s): Chantal Cases, Philippe Le Fur

More information

Preventive health-care system in France : Organisation, financement

Preventive health-care system in France : Organisation, financement Preventive health-care system in France : Organisation, financement Dr Martine Le Quellec-Nathan Sous-directrice Direction générale de la Santé Ministère de la santé et de la protection sociale VHPB Veyrier

More information

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA 1 CUTTING-EDGE ISSUES IN ASBESTOS LITIGATION CONFERENCE Scott Masterson Lewis, Brisbois, Bisgaard & Smith, LLP 1180 Peachtree Street, NE, Suite 2900

More information

Maladies chroniques et traumatismes Assessment of waterborne outbreaks investigated in France since 1998 and key recommendations

Maladies chroniques et traumatismes Assessment of waterborne outbreaks investigated in France since 1998 and key recommendations August 2008 Infectious diseases Health and environment Maladies chroniques et traumatismes Assessment of waterborne outbreaks investigated in France since 1998 and key recommendations Summary report During

More information

H E A D O F F I C E A N D L A B O R A T O R I E S

H E A D O F F I C E A N D L A B O R A T O R I E S INERIS in brief INERIS in a few words F O U N D E D I N 1 9 9 0 INERIS remit is to carry out, or to have carried out, studies and research that make it possible to prevent the risks that economic activities

More information

student population in 2005-2006

student population in 2005-2006 regional atlas student population in 2005-2006 Alsace Aquitaine Auvergne Burgundy Brittany Centre Champagne-Ardenne Corsica Franche-Comté Languedoc-Roussillon Limousin Lorraine Midi-Pyrénées North Pas-de-Calais

More information

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum Occupational respiratory diseases due to Asbestos Dirk Dahmann, IGF, Bochum Contents Introduction Diseases Further Effects Preventive Strategies Conclusion Asbestos minerals Woitowitz, 2003 Imports (+

More information

Table 2.4. Summary of design and findings from mesothelioma case-control studies

Table 2.4. Summary of design and findings from mesothelioma case-control studies categories Agudo et al. (2000) Barcelona and Cadiz, Spain 32 cases (77% males) of histologically con rmed malignant pleural mesothelioma identified from hospital in the region between //993 and 2/3/996.

More information

Mesothelioma: Questions and Answers

Mesothelioma: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions

More information

Pathology of Malignant Mesothelioma

Pathology of Malignant Mesothelioma Pathology of Malignant Mesothelioma Françoise Galateau-Sallé Pathology of Malignant Mesothelioma With 169 Figures, 158 in Full Color International Mesothelioma Panel Elisabeth Brambilla, Philip T. Cagle,

More information

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results. Proposed PAHO Plan of Action for Cancer Prevention and Control 2008 2015 Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

More information

Modernising environmental law in France : state of play and outlook

Modernising environmental law in France : state of play and outlook Modernising environmental law in France : state of play and outlook Rossella Pintus Directorate for Legal Affairs 19 February 2015 Crédit photo : Arnaud Bouissou/MEDDE Ministry of Ecology, Sustainable

More information

Malignant Mesothelioma

Malignant Mesothelioma Malignant Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)

More information

Malignant Mesothelioma

Malignant Mesothelioma Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)

More information

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden 596500SJP0010.1177/1403494815596500B. Järvholm and A. BurdorfAsbestos ban reduces mesothelioma incidence research-article2015 Scandinavian Journal of Public Health, 1 7 Original Article Emerging evidence

More information

Future trends in mortality of French men from mesothelioma

Future trends in mortality of French men from mesothelioma 488 Occup Environ Med 2;57:488 494 Future trends in mortality of French men from mesothelioma Alireza Banaei, Bertran Auvert, Marcel Goldberg, Alice Gueguen, Danièle Luce, Stephen Goldberg INSERM Unité

More information

Rare Thoracic Tumours

Rare Thoracic Tumours Rare Thoracic Tumours 1. Epithelial Tumour of Trachea 1 1.1 General Results Table 1. Epithelial Tumours of Trachea: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes Incidence Trend EAPC

More information

australian mesothelioma registry

australian mesothelioma registry australian mesothelioma registry 1st Annual Report Mesothelioma in Australia 2011 The Australian Mesothelioma Registry is funded by Safe Work Australia and Comcare. Creative Commons ISBN 978-0-642-78563-3

More information

Questions and Answers about the prevention of occupational diseases

Questions and Answers about the prevention of occupational diseases World Day for Safety and Health at Work 28 April 2013 Questions and Answers about the prevention of occupational diseases Occupational diseases cause huge suffering and loss in the world of work. Yet,

More information

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis [1]. Most are

More information

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos: A health hazard Exposure to asbestos was a major occupational health hazard in the United States. The first large-scale

More information

Munich Cancer Registry

Munich Cancer Registry Munich Cancer Registry Baseline statistics Selection Matrix Homepage Deutsch Munich Cancer Registry at Munich Cancer Center Marchioninistr. 15 Munich, 81377 Germany http://www.tumorregister-muenchen.de/en

More information

Information Notice. Regarding the insurance certificates Required under the IMO Conventions

Information Notice. Regarding the insurance certificates Required under the IMO Conventions Information Notice Regarding the insurance certificates Required under the IMO Conventions The purpose of this information notice is to detail the process of delivery of the insurance certificates required

More information

PREVENTION OF OCCUPATIONAL DISEASES

PREVENTION OF OCCUPATIONAL DISEASES THE PREVENTION OF OCCUPATIONAL DISEASES World Day for safety and health at work 28 April 2013 Outline The hidden epidemic: a global picture Assessing the need for better data Steps for the prevention of

More information

KAISER ALUMINUM & CHEMICAL CORPORATION ASBESTOS PERSONAL INJURY TRUST

KAISER ALUMINUM & CHEMICAL CORPORATION ASBESTOS PERSONAL INJURY TRUST KAISER ALUMINUM & CHEMICAL CORPORATION ASBESTOS PERSONAL INJURY TRUST Dual Claimants Frequently Asked Questions Q. How does the Trust review a lung cancer claim where the injured party also had silica

More information

Centre Jean Perrin. Centre de Lutte contre le Cancer d'auvergne CANCER CARE NETWORK

Centre Jean Perrin. Centre de Lutte contre le Cancer d'auvergne CANCER CARE NETWORK Centre Jean Perrin Centre de Lutte contre le Cancer d'auvergne Clermont-Ferrand - France - CANCER CARE NETWORK Mohun R K (Kailash) BAHADOOR Réseau Oncauvergne Centre Jean Perrin Clermont Ferrand WHY CANCER

More information

Insee. French National Institute of Statistics and Economic Studies. English edition. www.insee.fr. Fourth quarter 2010

Insee. French National Institute of Statistics and Economic Studies. English edition. www.insee.fr. Fourth quarter 2010 Insee French National Institute of Statistics and Economic Studies Fourth quarter 2010 English edition Historical summary France established its first statistical agency, Statistique Générale de la France,

More information

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON* PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON* M. L. Newhouse TUC Centenary Institute of Occupational Health London School of Hygiene and Tropical Medicine London WCIE 7HT. England G. Berry

More information

THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)

THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR) THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR) Professor Nico van Zandwijk Director Asbestos Diseases Research Institute US US UK UK COUNTRY NZ CAN COUNTRY NZ CAN AUS AUS Mesothelioma International context

More information

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012)

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012) Mesothelioma in Australia: Incidence (1982 to 213) and Mortality (1997 to 212) 215 Disclaimer The information provided in this document can only assist you in the most general way. This document does not

More information

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York www.ierfinc.

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York www.ierfinc. Scientific Update on Safe Use of Asbestos Robert P. Nolan, PhD International Environmental Research Foundation New York, New York www.ierfinc.org When We Talk about Asbestos What Do We Mean? Anthophyllite

More information

Exploring the Role of Vitamins in Achieving a Healthy Heart

Exploring the Role of Vitamins in Achieving a Healthy Heart Exploring the Role of Vitamins in Achieving a Healthy Heart There are many avenues you can take to keep your heart healthy. The first step you should take is to have a medical professional evaluate the

More information

Estimating the Global Burden of Asbestos-related Diseases Using YPLL

Estimating the Global Burden of Asbestos-related Diseases Using YPLL Ramazzini Days Carpi, Italy October, 2012 Estimating the Global Burden of Asbestos-related Diseases Using YPLL Ken Takahashi 1, Ying Jiang 1, Mehrnoosh Movahed 1, Giang Vinh Le 2,1, Eun-Kee Park 3,1, Rokho

More information

MESOTELIOMA and CHRYSOTILE

MESOTELIOMA and CHRYSOTILE MESOTELIOMA and CHRYSOTILE in RUSSIA Kashansky S.V., Grinberg L.M., Kuzmin S.V., Berdnikov R.B., Berzin S.A. Ekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers

More information

Mesothelioma Priority Setting Partnership. PROTOCOL November 2013

Mesothelioma Priority Setting Partnership. PROTOCOL November 2013 Mesothelioma Priority Setting Partnership PROTOCOL November 2013 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the Mesothelioma Priority Setting Partnership

More information

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2008 MORTALITY 1997 TO 2007

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2008 MORTALITY 1997 TO 2007 MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 28 MORTALITY 1997 TO 27 August 212 Safe Work Australia Mesothelioma in Australia Incidence 1982 to 28 Deaths 1997 to 27 August 212 Acknowledgement Data on the

More information

Sir William Osler: Listen to the patient; the patient tells you everything.

Sir William Osler: Listen to the patient; the patient tells you everything. Sir William Osler: Listen to the patient; the patient tells you everything. Jean-Martin Charcot: The patient is a liar. Epidemiology of Mesothelioma Jeffrey H. Mandel, MD, MPH Division of Environmental

More information

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2009 MORTALITY 1997 TO 2011

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2009 MORTALITY 1997 TO 2011 MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 29 MORTALITY 1997 TO 211 OCTOBER 213 Safe Work Australia Mesothelioma in Australia Incidence 1982 to 29 Mortality 1997 to 211 OCTOBER 213 Acknowledgement Disclaimer

More information

Weekly Review of the Negotiable Debt Securities Market from 19/12/2015 au 25/12/2015

Weekly Review of the Negotiable Debt Securities Market from 19/12/2015 au 25/12/2015 Directorate General Operations Financial Stability Short and Medium-Term Securities Division Weekly Review of the Negotiable Debt Securities Market from 19/12/2015 au Negotiable Medium-term Notes stcn.publi@banque-france.fr

More information

NC General Statutes - Chapter 130A Article 7 1

NC General Statutes - Chapter 130A Article 7 1 Article 7. Chronic Disease. Part 1. Cancer. 130A-205. Administration of program; rules. (a) The Department shall establish and administer a program for the prevention and detection of cancer and the care

More information

ASBESTOS-RELATED DISEASES IN QUEBEC

ASBESTOS-RELATED DISEASES IN QUEBEC REPORT THE EPIDEMIOLOGY OF ASBESTOS-RELATED DISEASES IN QUEBEC SUB-COMMITTEE ON THE EPIDEMIOLOGY OF ASBESTOS-RELATED DISEASES IN QUEBEC JULY 2004 AUTHORS Members of the sub-committee on the epidemiology

More information

OVERVIEW MESOBANK: COHORT INNOVATION DAY 89

OVERVIEW MESOBANK: COHORT INNOVATION DAY 89 : Clinicobiological database on mesothelioma ITMO Santé publique Lyon Prof. Françoise Galateau Sallé Professor of Pathology, Centre Leon Bérard (French cancer center), Lyon, France OVERVIEW AT A GLANCE

More information

The French National Program for Mesothelioma Surveillance

The French National Program for Mesothelioma Surveillance Occupational Health The French National Program for Mesothelioma Surveillance Principal results 1998-2006 Institut interuniversitaire de médecine du travail de Paris Île-de-France Contents 1. Main features

More information

Asbestos and the diseases it causes

Asbestos and the diseases it causes Asbestos and the diseases it causes October 2013 Liz Darlison Mesothelioma UK University Hospitals of Leicester Contents What is asbestos Why is it such an issue in the UK Disease Statistics Asbestos Related

More information

PROTOCOL OF THE RITA DATA QUALITY STUDY

PROTOCOL OF THE RITA DATA QUALITY STUDY PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of

More information

LIFE INSURANCE COMPANY OF NORTH AMERICA (herein called the Company)

LIFE INSURANCE COMPANY OF NORTH AMERICA (herein called the Company) LIFE INSURANCE COMPANY OF NORTH AMERICA (herein called the Company) Amendment to be attached to and made a part of the Group Policy A Contract between the Company and Payless ShoeSource, Inc. (herein called

More information

Chronic pain: identification, assessment and referral of patient with chronic pain syndrome

Chronic pain: identification, assessment and referral of patient with chronic pain syndrome CLINICAL PRACTICE GUIDELINE Chronic pain: identification, assessment and referral of patient with chronic pain syndrome Formal consensus GUIDELINE December 2008 The scientific report to this guidelinecan

More information

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.

More information

FITCH AFFIRMS GROUPE BPCE AT 'A+'

FITCH AFFIRMS GROUPE BPCE AT 'A+' FITCH AFFIRMS GROUPE BPCE AT 'A+' Fitch Ratings-London-11 October 2011: Fitch Ratings has affirmed Groupe BPCE's (GBCPE), BPCE S.A.'s (GBPCE's central body) and Natixis's Long-term Issuer Default Ratings

More information

The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in:

The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in: Reference Centre for Asbestos Exposure &Health Risk Assessment The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in: NEONILA SZESZENIA-DĄBROWSKA, BEATA ŚWIŚTKOWSKA,

More information

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007 Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update December 7, 2007 Center for Occupational Health and Safety Chronic Disease and Environmental Epidemiology Section Minnesota

More information

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007 Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update December 7, 2007 Center for Occupational Health and Safety Chronic Disease and Environmental Epidemiology Section Minnesota

More information

P L E U R A L M E S O T H E L I O M A

P L E U R A L M E S O T H E L I O M A For media outside the US, UK and Canada only P L E U R A L M E S O T H E L I O M A 1. Overview 2. What is pleural mesothelioma? 3. How common is pleural mesothelioma? 4. What are the risk factors for pleural

More information

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006 Multiple Myeloma Figure 16 Definition: Multiple myeloma forms in plasma cells that are normally found in the bone marrow. 1 The plasma cells grow out of control and form tumors (plasmacytoma) or crowd

More information

Association de Science Régionale De Langue Française LOOKING FOR REGIONAL DISPARITIES

Association de Science Régionale De Langue Française LOOKING FOR REGIONAL DISPARITIES Association de Science Régionale De Langue Française XLème Colloque de l ASRDLF Convergence et disparités régionales au sein de l espace européen Les politiques régionales à l épreuve des faits Bruxelles

More information

National Cancer Institute

National Cancer Institute National Cancer Institute Information Systems, Technology, and Dissemination in the SEER Program U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Information Systems, Technology,

More information

in France Engineering Labour Force What Employers Need to Know Rates of Pay Where to Recruit

in France Engineering Labour Force What Employers Need to Know Rates of Pay Where to Recruit Engineering Labour Force in France Engineering Labour Force What Employers Need to Know Rates of Pay Where to Recruit 1 French engineers are internationally mobile: 13.1 per cent of French graduate engineers

More information

ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER

ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER OCCUPATIONAL CANCER EPIDEMIOLOGY Round Table organized by the Public Health Institute from Bucharest Information pack for the participants, provided by dr. Dana

More information

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center Changing Trends in Mesothelioma Incidence Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center International Conference on Chrysotile Montreal, May 23, 2006 Global Mesothelioma

More information

ow centres of expertise should interface with social services The French experience : state of the art and current challenges

ow centres of expertise should interface with social services The French experience : state of the art and current challenges ow centres of expertise should interface with social services The French experience : state of the art and current challenges Christel Nourissier EURORDIS EUROPLAN Advisor 2 strategic Plans for rare diseases

More information

A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine November 3, 2008

A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine November 3, 2008 A Cross-Sectional Study of Asbestos- Related Morbidity and Mortality in Vermonters Residing Near an Asbestos Mine 108 Cherry Street, PO Box 70 Burlington, VT 05402 802.863.7200 healthvermont.gov A Cross-Sectional

More information

Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers

Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers Table of Contents WS-E-12 Xing Zhang Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers Xing Zhang 1, Tong-da Sun 2, Nan-feng Shi 2, Li-qiu Zhu 1, Kenji Morinaga 3 1 Institute

More information

Korea Environmental Policy Bulletin

Korea Environmental Policy Bulletin KEPB Issue 4, Volume IX, 2011 Korea Environmental Policy Bulletin Asbestos Damage Relief System CONTENTS I. Background and Purpose II. Major Details of the Act on Asbestos Damage Relief and the Procedure

More information

Uses and Abuses of Pathology in Asbestos-exposed Populations

Uses and Abuses of Pathology in Asbestos-exposed Populations Uses and Abuses of Pathology in Asbestos-exposed Populations Jerrold L. Abraham, MD Department of Pathology State University of New York Upstate Medical University Syracuse, NY, 13210 USA The term: Asbestosis,

More information

INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST

INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST The Celotex Asbestos Settlement Trust (Celotex Trust) was established as a result of the bankruptcy of the Celotex Corporation

More information

Asbestos Diseases Uncovered

Asbestos Diseases Uncovered Asbestos Diseases Uncovered Your complete download & keep guide to asbestos-related diseases. Their symptoms, causes and potential compensation payable Contents What is Asbestos? What diseases are caused

More information

Incorrect Analyses of Radiation and Mesothelioma in the U.S. Transuranium and Uranium Registries Joey Zhou, Ph.D.

Incorrect Analyses of Radiation and Mesothelioma in the U.S. Transuranium and Uranium Registries Joey Zhou, Ph.D. Incorrect Analyses of Radiation and Mesothelioma in the U.S. Transuranium and Uranium Registries Joey Zhou, Ph.D. At the Annual Meeting of the Health Physics Society July 15, 2014 in Baltimore A recently

More information

(Sample from The Altman Group Ballot Archive) Ballot No. 1 - Individual Ballot for Class 7 Direct Asbestos PI Claims

(Sample from The Altman Group Ballot Archive) Ballot No. 1 - Individual Ballot for Class 7 Direct Asbestos PI Claims UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re USG CORPORATION, a Delaware corporation, et al., 1 Debtors. Chapter 11 Jointly Administered Case No. 01-2094 (JKF) INDIVIDUAL BALLOT FOR ACCEPTING

More information

Asbestos exposure is the only well-established. Temporal patterns of occupational asbestos exposure and risk of pleural mesothelioma

Asbestos exposure is the only well-established. Temporal patterns of occupational asbestos exposure and risk of pleural mesothelioma Eur Respir J 2012; 39: 1304 1312 DOI: 10.1183/09031936.00005111 CopyrightßERS 2012 Temporal patterns of occupational asbestos exposure and risk of pleural mesothelioma Aude Lacourt*,#, Karen Leffondré*,

More information

The Belgian Asbestos Fund

The Belgian Asbestos Fund The Belgian Asbestos Fund Dr. Marc Vandeweerdt Occupational Diseases Fund - Asbestos Fund 22 January 2011 Asbestos: history Asbestos consumption in Europe 1920: 39,276 T 1950: 369,738 T 1975: 1,410,394

More information

Output URL Radio France. France Info.

Output URL Radio France.  France Info. Radio Output URL Radio France France Info http://direct.franceinfo.fr/live/franceinfo-midfi.mp3 http://direct.franceinfo.fr/live/franceinfo-lofi.mp3 France Inter FIP Nat FIP Bordeaux http://direct.franceinter.fr/live/franceinter-midfi.mp3

More information

Asbestos related health risks

Asbestos related health risks Asbestos related health risks Pascal DUMORTIER *,** & Paul DE VUYST** *a-ulab ** Chest Department Hopital ERASME Asbestos related health risks Asbestos : some facts Asbestos related diseases Detection

More information

Report of Working Groups

Report of Working Groups BD5.3 Report of Working Groups Elimination of Asbestos-related Diseases ICOH 2012 March 18, 2012 Cancun Report of WG Elimination of Asbestos-related Diseases Dr. Sherson mail to ICOH President of 7 December

More information

REPUBLIC OF SOUTH AFRICA

REPUBLIC OF SOUTH AFRICA Government Gazette REPUBLC OF SOUTH AFRCA Vol. 448 Pretoria 23 October 2002 No. 23969 ADS HELPLNE: 0800-0123-22 Prevention is the cure ~ 2 No. 23969 GOVERNMENT GAZETTE, 23 OCTOBER 2002 - No. Page Gazette

More information

Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi

Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi 27 slides to go Who are we? I am an epidemiologist/biostatistician from the Australian

More information

- Compensation issues

- Compensation issues Charité- Universitätsmedizin Berlin Institut für Arbeitsmedizin Prof. Dr. med. X. Baur Prevention, recognition and compensation of asbestosinduced diseases (AD) - Which diseases are asbestos-related? -

More information

DECISION NO. 94/91. Exposure (asbestos).

DECISION NO. 94/91. Exposure (asbestos). DECISION NO. 94/91 Exposure (asbestos). The worker appealed a decision of the Hearings Officer denying entitlement for asbestosis which the worker related to exposure to asbestos when the building in which

More information

Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma

Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Disease Markers Volume 2015, Article ID 282145, 5 pages http://dx.doi.org/10.1155/2015/282145 Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma Emanuela Taioli,

More information

Transcript for Asbestos Information for the Community

Transcript for Asbestos Information for the Community Welcome to the lecture on asbestos and its health effects for the community. My name is Dr. Vik Kapil and I come to you from the Centers for Disease Control and Prevention, Agency for Toxic Substances

More information

Burns and Roe Asbestos Personal Injury Settlement Trust Instructions for Filing Claims

Burns and Roe Asbestos Personal Injury Settlement Trust Instructions for Filing Claims The Burns and Roe Asbestos Personal Injury Settlement Trust (the "Trust") was established pursuant to the Plan of Reorganizaton of Burns and Roe Enterprises, Inc., and Burns and Roe Construction Group,

More information

ADVICE to safety representatives

ADVICE to safety representatives UNITE LEGAL SERVICES - TRUST YOUR UNION ADVICE to safety representatives Unite has launched a new asbestos campaign aiming to: Raise members awareness of asbestos hazards at work Provide advice to Unite

More information

Review of Eliminating occupational cancer in Europe and globally by J. Takala

Review of Eliminating occupational cancer in Europe and globally by J. Takala Review of Eliminating occupational cancer in Europe and globally by J. Takala There primary concerns of this manuscript are outlined below. More detail discussion of these points is presented on the following

More information

FITCH DOWNGRADES MAJOR FRENCH BANKS' RELATED ENTITIES

FITCH DOWNGRADES MAJOR FRENCH BANKS' RELATED ENTITIES FITCH DOWNGRADES MAJOR FRENCH BANKS' RELATED ENTITIES Fitch Ratings-Paris/London-17 July 2013: Fitch Ratings has downgraded several of BNP Paribas' (BNPP), Credit Agricole's (CA), Societe Generale's (SG),

More information

Asbestosis: data to explore. From 1981 to 1996, 116 Quebecers died of

Asbestosis: data to explore. From 1981 to 1996, 116 Quebecers died of révention ASBESTOS Changing realities Some people may think that the issue of asbestos-related diseases has been resolved, or at least well documented in Quebec. They should think again. Unexplained data

More information